A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function
Clinical trial NCT02399202 · COMPLETED
Trial details
- NCT number
- NCT02399202
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-06
- Primary completion
- 2016-03-21
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.